We describe a postnatally diagnosed case of Walker-Warburg syndrome--a form of congenital muscular dystrophy with lissencephaly and eye abnormalities. We reviewed the literature to highlight its clinico-radiological diagnostic features and discuss the difficulties encountered with prenatal diagnosis, especially in cases with no positive family history. An increased awareness of this rare but lethal condition, and a high index of suspicion during routine antenatal ultrasound, could prompt further advanced fetal ultrasonography and magnetic resonance imaging, and aid in timely prenatal diagnosis, management, and counseling.
To identify if ultrasound measurement of endometrial thickness is predictor of retained products of conception in women with clinical suspicion of incomplete miscarriage. Methods: This was a prospective study of 100 women with a diagnosis of incomplete miscarriage who were referred for surgical evacuation. All women had a positive pregnancy test and ultrasound findings suggestive of retained product of conception. The indication for intervention was heavy vaginal bleeding or the endometrial thickness above 15 mm on antero-posterior diameter. The final diagnosis of incomplete miscarriage was based on histopathologic evidence of chorionic villi in the surgical specimen. Results: 90 (90%) women with endometrial thickness above 15 mm had evidence of chorionic villi on histology and decidua was only found in the remaining 10 (10%) women. Conclusion: Considering 90% positive predictive value, the measurement of endometrial thickness is good predictor of retained product of conception.
Introduction: Intrauterine growth restriction (IUGR) is a major cause of perinatal morbidity and mortality. IUGR is characterized by the presence of a fetus with a weight lower than the 10 th centile for gestational age estimated by ultrasound examination or a delivery of a neonate with a birth weight lower than 2.5 kg at term. The causes of IUGR are divided into fetal, placental and maternal ones. Maternal anemia, malnutrition, infections (rubella, cytomegalovirus), toxic substances (alcohol, smoking) may affect fetal growth. Objectives: The aim of the study was to determine the relationship between the low maternal plasma glucose level after glucose challenge test (GCT) and fetal growth restriction. Material and Methods: The studied population consisted of 141 pregnant women with a singleton gestation. The women underwent the GCT between the 24 th and 27 th week of pregnancy. In all patients ultrasound examination was performed between 20 th and 24 th week of gestation and the estimated fetal weight (EFW) was evaluated. Low maternal plasma glucose level after GCT was defined as less than 100mg/dL. Patients with glucose level higher than 140mg/dL after GCT were excluded from the study. The data obtained from the remaining women (n = 134) were compared with the fetal birth weight measured after delivery. The Yates' chi-square test was used to perform statistical calculation. Results: The frequency of IUGR in the studied population was 12.6% (17/134). Conclusion:The study showed that in women with the plasma glucose levels lower than 100 mg/dL after GCT the frequency of IUGR was significantly higher than in those with normal results of GCT. P20.09: Incidence of IUGR by glucose challenge test results GCT Normal Low Total IUGR
Poster abstracts 88.7%, 86.8% and 92.5% for CD, PD and e-flow, respectively. Negative and positive predictive values for e-flow estimation were 97.4% and 78.6%, respectively. Prognostic values of analyzed methods in our group of patients based on the area under ROC was: 0.940, 0.945 and 0.960 respectively. Conclusion: E-flow technology applied in ultrasonographic Doppler index is useful to make a prognosis of ovarian tumor malignancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.